(19)
(11) EP 0 726 777 A1

(12)

(43) Date of publication:
21.08.1996 Bulletin 1996/34

(21) Application number: 94932028.0

(22) Date of filing: 25.10.1994
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 38/ 00( . )
A61K 39/ 385( . )
A61P 29/ 00( . )
A61P 43/ 00( . )
C12N 1/ 21( . )
C12P 21/ 02( . )
A61K 9/ 127( . )
A61K 39/ 00( . )
A61P 25/ 00( . )
A61P 37/ 00( . )
C07K 14/ 74( . )
C12N 15/ 12( . )
C12R 1/ 19( . )
(86) International application number:
PCT/US1994/012231
(87) International publication number:
WO 1995/011702 (04.05.1995 Gazette 1995/19)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 25.10.1993 US 19930143575

(71) Applicant: ANERGEN, INC.
Redwood City, CA 94063 (US)

(72) Inventors:
  • RHODES, Eric T.
    Vallejo, CA 94591 (US)
  • NAG, Bishwajit
    Pacifica, CA 94044 (US)

(74) Representative: Walton, Seán Malcolm, et al 
Mewburn Ellis, York House, 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) PROKARYOTIC EXPRESSION OF MHC PROTEINS